
Commentary|Articles|August 26, 2026
Beyond the itch: Recognizing vision-threatening eye allergy in children
Author(s)Kassi Filkins, Angela Zhu, MD
Angela Y. Zhu, MD, of Bascom Palmer Eye Institute, explains how to distinguish eye allergy from vision-threatening VKC and AKC in children and when steroid-sparing therapy and referral are warranted.
Advertisement
Advertisement
Children's Eye Health and Safety Month centers largely on vision screening and injury prevention, but allergic eye disease is a quietly common—and sometimes vision-threatening—part of pediatric eye care. Seasonal and perennial allergic conjunctivitis affect a large share of children, while more severe forms such as vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC) can progress to shield ulcers, corneal scarring, and lasting visual compromise if missed.
Related to this article

Josef Huemer, MD, discusses retinal changes linked to atrial fibrillation and what they mean for eye care clinicians.

Kiril Kiprovski, MD, of NYU Langone shares clinical clues and bedside tests for spotting Lambert-Eaton myasthenic syndrome.

The non-invasive device, already available in Canada, Australia, and New Zealand, delivers low-level microcurrent through closed eyelids in 32-minute in-clinic sessions.

The agreement brings J&J a next-generation bispecific antibody that outpaced faricimab on early anatomic measures in the phase 1b JADE trial, with Blackstone Life Sciences committing $750 million to fund phase 3 development.

A systemic Sjögren therapy would make earlier identification more actionable for ophthalmologists, Esen K. Akpek, MD, said.

The first-in-human study of the GalNAc-conjugated siRNA joins a fast-moving Stargardt pipeline as the FDA weighs the first potential approval for the disease.
Advertisement
Advertisement


